GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walpar Nutritions Ltd (NSE:WALPAR) » Definitions » Capex-to-Revenue

Walpar Nutritions (NSE:WALPAR) Capex-to-Revenue : 0.27 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Walpar Nutritions Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Walpar Nutritions's Capital Expenditure for the six months ended in Sep. 2022 was ₹-44.24 Mil. Its Revenue for the six months ended in Sep. 2022 was ₹165.20 Mil.

Hence, Walpar Nutritions's Capex-to-Revenue for the six months ended in Sep. 2022 was 0.27.


Walpar Nutritions Capex-to-Revenue Historical Data

The historical data trend for Walpar Nutritions's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walpar Nutritions Capex-to-Revenue Chart

Walpar Nutritions Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
Capex-to-Revenue
0.08 0.03 0.03 0.31 0.14

Walpar Nutritions Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22
Capex-to-Revenue Get a 7-Day Free Trial - - 0.01 0.30 0.27

Competitive Comparison of Walpar Nutritions's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Walpar Nutritions's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walpar Nutritions's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walpar Nutritions's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Walpar Nutritions's Capex-to-Revenue falls into.



Walpar Nutritions Capex-to-Revenue Calculation

Walpar Nutritions's Capex-to-Revenue for the fiscal year that ended in Mar. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-38.443) / 267.574
=0.14

Walpar Nutritions's Capex-to-Revenue for the quarter that ended in Sep. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-44.236) / 165.196
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Walpar Nutritions  (NSE:WALPAR) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Walpar Nutritions Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Walpar Nutritions's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Walpar Nutritions (NSE:WALPAR) Business Description

Traded in Other Exchanges
N/A
Address
Khatraj, 2nd Floor L5:377 Plot No 5, Omkar Estate, Opposite Sabarmati Gas Station, Kalol, Gandhinagar, GJ, IND, 382721
Walpar Nutritions Ltd is primarily engaged in manufacturing and trading of Pharmaceutical, Nutraceutical, Herbal, and Ayurvedic commodities.

Walpar Nutritions (NSE:WALPAR) Headlines

No Headlines